TNDM Tandem Diabetes Care: Utang jangka cendhak perusahaan

Logo perusahaan publik Tandem Diabetes Care (TNDM)

The growth of Tandem Diabetes Care (TNDM) is being hindered by the expansion of GLP-1 drugs and potential disruptions in updating its device lineup. Simultaneously, the company is implementing eco-friendly electronics recycling and reducing plastic packaging. The business relies on a streamlined component delivery system, which supports high sales profitability. This chart illustrates the asset's market value on GURU.Markets, which is fixed at 0.00, reflecting the price action of the insulin pump manufacturer.

TNDM (Tandem Diabetes Care, Inc.) riwayat Utang jangka cendhak perusahaan saka 04.07.2022 nganti 01.11.2026
Produk sing diprodhuksi tandemdiabetes.com

Tandem Diabetes Care maintains a strong position due to high patient loyalty toward automated insulin pumps. The 0.00 metric digitizes the value of liabilities with maturities of up to one year required to maintain the technological cycle. An increase in such borrowings typically reflects working capital expansion during sales scaling. However, excessive leverage increases the probability of a liquidity shortage if demand falls. The volume of short-term loan capital clearly demonstrates the dynamics of these risks.

Pesaing utama

Boston Scientific Corporation - Utang jangka cendhak perusahaan|Edwards (EW) - Kewajiban jangka cendhak perusahaan|RMD: Utang jangka cendhak perusahaan|PODD - Gunggunge utang jangka cendhak|ZBH (Zimmer Biomet Holdings Inc) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan coopercos.com|Utang jangka cendhak perusahaan Align Technology (ALGN)|Utang jangka cendhak perusahaan GMED (Globus Medical Inc)|Utang jangka cendhak perusahaan TMDX (transmedics.com)|Gunggunge utang jangka cendhak Alphatec Corp (ATEC)|AORT: Kewajiban jangka cendhak perusahaan|Kewajiban jangka cendhak ENOV|IART: Utang jangka cendhak perusahaan|Utang jangka cendhak Establishment Labs Corp (ESTA)|BBNX (Beta Bionics Corp) - Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan IRMD (IRADIMED Inc.)|Kewajiban jangka cendhak perusahaan EMBC (Embecta Corp.)|AXGN (axogeninc.com) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan SI-BONE SIBN|OFIX - Kewajiban jangka cendhak perusahaan|Bioventus Corp - Utang jangka cendhak perusahaan|Utang jangka cendhak OrthoPediatrics Corp.|TMCI: Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan SRTA|CARL (Carlsmed) - Utang jangka cendhak perusahaan|RxSight Inc (RXST) - Gunggunge utang jangka cendhak|Utang jangka cendhak perusahaan CLPT|Kewajiban jangka cendhak perusahaan Stereotaxis Corporation STXS|Utang jangka cendhak perusahaan STIM (Neuronetics, Inc.)|Utang jangka cendhak perusahaan sightsciences.com SGHT|OBIO - Utang jangka cendhak perusahaan|ANIK: Utang jangka cendhak perusahaan|NSPR (InspireMD Corp) - Kewajiban jangka cendhak perusahaan|Jin Medical - Silihan lan utang jangka cendhak perusahaan|VANI (Vivani Medical Inc) - Utang jangka cendhak perusahaan|Utang jangka cendhak Xtant Medical Inc XTNT|Utang jangka cendhak perusahaan NeuroOne Medical Technologies Corporation (NMTC)|modular-medical.com (MODD) - Tanggungan jangka cendhak|Myomo, Inc - Kewajiban jangka cendhak perusahaan|Utang jangka cendhak perusahaan Envoy Medical Inc COCH|Vivos Therapeutics - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak envveno.com NVNO|sintx.com (SINT) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak TNON (Tenon Medical Inc.)|Utang jangka cendhak perusahaan ReWalk Robotics Ltd|Kewajiban jangka cendhak perusahaan Autonomix (AMIX)|Utang jangka cendhak perusahaan IVF|BBLG - Utang jangka cendhak|Utang jangka cendhak perusahaan Axonics AXNX|BIOL: Tanggungan utang jangka cendhak perusahaan|DYNT: Kewajiban jangka cendhak perusahaan|Paragon 28, Inc. - Gedhene kewajiban jangka cendhak|INVO (invobioscience.com) - Kewajiban jangka cendhak perusahaan